Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of peripheral blood DNA methylation level with Alzheimer’s disease progression

15 Oct 2021

Abstract excerpt

Abstract Background Identifying biomarkers associated with Alzheimer’s disease (AD) progression may enable patient enrichment and improve clinical trial designs. Epigenome-wide association studies have revealed correlations between DNA methylation at cytosine-phosphate-guanine (CpG) sites and AD pathology and diagnosis. Here, we report relationships between peripheral blood DNA methylation profiles measured using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Epigenetics and DNA Methylation
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34654479
DOI: 10.1186/s13148-021-01179-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of peripheral blood DNA methylation level with Alzheimer’s disease progressionPMID 34654479Read ↗

Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.Semantic proximity Read ↗

Methylation risk score in peripheral blood predictive of conversion from mild cognitive impairment to Alzheimer's DiseaseSemantic proximity Read ↗

Blood‐based multivariate methylation risk score for cognitive impairment and dementiaSemantic proximity Read ↗

Blood DNA methylation signatures to detect dementia prior to overt clinical symptomsSemantic proximity Read ↗

Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive statusSemantic proximity Read ↗

Sixteen-year longitudinal evaluation of blood-based DNA methylation biomarkers for early prediction of Alzheimer’s diseaseSemantic proximity Read ↗

Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive statusSemantic proximity Read ↗

Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's diseaseSemantic proximity Read ↗

Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjectsSemantic proximity Read ↗

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progressionSemantic proximity Read ↗

Epigenome-wide analyses identify DNA methylation signatures of dementia riskSemantic proximity Read ↗

From aging to Alzheimer’s disease: concordant brain DNA methylation changes in late lifeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.